Open-access Comparative Evaluation of the Efficacy of Human Periostin and Enamel Matrix Derivative (Emdogain®) on Proliferation and Migration of Periodontal Ligament Fibroblasts

ABSTRACT

Objective:  To explore the proliferative and wound-healing potential of Periostin and Emdogain® on periodontal fibroblasts.

Material and Methods:  Human PDL (hPDL) fibroblasts were cultured and treated with two biological agents, Emdogain® and Periostin. The Dulbecco's Modified Eagle Medium (DMEM) served as the control. The cytotoxic effects of Emdogain® and Periostin were analyzed using the Clonogenic assay. Cell viability was estimated using the CCK-8 assay. Further, the migratory potential of the hPDL fibroblasts was assessed using the scratch migration assay.

Results:  The results showed that 1/1000 dilution of Emdogain® and 1/10 dilution of Periostin had the highest cell survival fraction (p<0.05). In the CCK-8 assay, Emdogain® displayed maximum cell viability compared to Periostin (p=0.000) and control (p=0.006). The PDL fibroblasts' migratory rate corresponded to the experimental agents' wound-healing potential. Emdogain® presented with earlier wound closure compared to Periostin (p=0.002) and control (p=0.000).

Conclusion:  Thus, based on the results of this study, Periostin may be a viable biologic agent for promoting periodontal regeneration.

Keywords:
Periostin; Guided Tissue Regeneration, Periodontal; Wound Healing; Periodontal Ligament

location_on
Associação de Apoio à Pesquisa em Saúde Bucal Avenida Epitácio Pessoa, 4161 - Sala 06, Miramar, CEP: 58020-388, João Pessoa, PB - Brasil, Tel.: 55-83-98773 2150 - João Pessoa - PB - Brazil
E-mail: apesb@terra.com.br
rss_feed Acompanhe os números deste periódico no seu leitor de RSS
Reportar erro